0001127602-23-022117.txt : 20230807
0001127602-23-022117.hdr.sgml : 20230807
20230807160517
ACCESSION NUMBER: 0001127602-23-022117
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230803
FILED AS OF DATE: 20230807
DATE AS OF CHANGE: 20230807
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: CASPER MARC N
CENTRAL INDEX KEY: 0001216055
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-08002
FILM NUMBER: 231147559
MAIL ADDRESS:
STREET 1: C/O THERMO FISHER SCIENTIFIC
STREET 2: 168 THIRD AVENUE
CITY: WALTHAM
STATE: MA
ZIP: 02451
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: THERMO FISHER SCIENTIFIC INC.
CENTRAL INDEX KEY: 0000097745
STANDARD INDUSTRIAL CLASSIFICATION: MEASURING & CONTROLLING DEVICES, NEC [3829]
IRS NUMBER: 042209186
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 168 THIRD AVENUE
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: 7816221000
MAIL ADDRESS:
STREET 1: 168 THIRD AVENUE
CITY: WALTHAM
STATE: MA
ZIP: 02451
FORMER COMPANY:
FORMER CONFORMED NAME: THERMO ELECTRON CORP
DATE OF NAME CHANGE: 19920703
4
1
form4.xml
PRIMARY DOCUMENT
X0508
4
2023-08-03
0000097745
THERMO FISHER SCIENTIFIC INC.
TMO
0001216055
CASPER MARC N
168 THIRD AVENUE
WALTHAM
MA
02451
1
1
Chairman & CEO
1
Common Stock
2023-08-03
4
M
0
10000
157.68
A
151329.53
D
Common Stock
2023-08-03
4
S
0
300
545.66
D
151029.53
D
Common Stock
2023-08-03
4
S
0
1600
547.43
D
149429.53
D
Common Stock
2023-08-03
4
S
0
3000
548.25
D
146429.53
D
Common Stock
2023-08-03
4
S
0
1900
549.38
D
144529.53
D
Common Stock
2023-08-03
4
S
0
2100
550.33
D
142429.53
D
Common Stock
2023-08-03
4
S
0
1100
551.09
D
141329.53
D
Common Stock
2023-08-03
5
G
0
E
3300
0
D
0
I
By Spouse
Common Stock
2023-08-03
5
G
0
E
3300
0
A
5300
I
By Alison Casper 2020 Irrevocable Trust
Common Stock
2023-08-03
5
G
0
E
6000
0
D
135329.53
D
Common Stock
2023-08-03
5
G
0
E
6000
0
A
6000
I
By Spouse
Common Stock
2023-08-04
4
M
0
10000
157.68
A
145329.53
D
Common Stock
2023-08-04
4
S
0
1200
547.55
D
144129.53
D
Common Stock
2023-08-04
4
S
0
1627
548.61
D
142502.53
D
Common Stock
2023-08-04
4
S
0
2400
549.57
D
140102.53
D
Common Stock
2023-08-04
4
S
0
1441
550.40
D
138661.53
D
Common Stock
2023-08-04
4
S
0
1432
551.49
D
137229.53
D
Common Stock
2023-08-04
4
S
0
600
552.72
D
136629.53
D
Common Stock
2023-08-04
4
S
0
900
553.76
D
135729.53
D
Common Stock
2023-08-04
4
S
0
400
554.56
D
135329.53
D
Common Stock
59155
I
By Floral Park Associates, Inc.
Common Stock
5000
I
By MNC 2020 Irrevocable Trust
Stock Option (Right to Buy)
157.68
2023-08-03
4
M
0
10000
0
D
2024-02-28
Common Stock
10000
53200
D
Stock Option (Right to Buy)
157.68
2023-08-04
4
M
0
10000
0
D
2024-02-28
Common Stock
10000
43200
D
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 18, 2022.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $546.835 to $547.83, inclusive. The reporting person undertakes to provide to Thermo Fisher Scientific Inc. ("TMO"), any security holder of TMO or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3), (4), (5), (6), (9), (10), (11), (12), (13), (14), (15) and (16) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $547.84 to $548.83, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $548.84 to $549.835, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $549.84 to $550.815, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $550.845 to $551.41, inclusive.
Effective February 27, 2023, donations of equity securities are to be reported on a Form 4 within two business days rather than on Form 5 within 45 days after the end of the fiscal year. Although the identifying "V" for donations made before February 27 and reported early on Form 4, the "V' is not appropriate for the donation reported on this Form 4. The "V" is included here due solely to a limitation in the issuer's filing software which is currently being reprogrammed.
The reporting person disclaims beneficial ownership of the securities reported herein as indirectly beneficially owned, except to the extent of any pecuniary interest therein.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $546.99 to $547.97, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $548.03 to $549.00, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $549.04 to $550.01, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $550.06 to $550.95, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $551.12 to $551.99, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $552.18 to $553.06, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $553.19 to $554.155, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $554.31 to $554.83, inclusive.
The option vested in four equal installments on February 28, 2018, 2019, 2020, and 2021.
/s/ Melodie T. Morin, Attorney-in-Fact for Marc N. Casper
2023-08-07